Table 1.

Antimicrobial susceptibility profile of MRSA isolates according to antimicrobial classes in PLHA treated at the HC/UFPE DIP service

Samples	Antimicrobial resistance
SN 65	ERI, CLI, PEN
SN 109	CFO, CLO, GEN, ERI, CLI, PEN, SUT
SN 111	ERI, PEN, SUT
SN 133	CFO, CLO, CLI, PEN
SN 170	CFO, CLO, CIP, GEN, ERI, CLIN, PEN, SUT
SN 172	CFO, GEN, ERI, CLI, PEN, SUT
SN 193	CFO, GEN, ERI, CLI, PEN, SUT
SN 211	CFO, PEN
SN 241	CFO, ERI, PEN, SUT
SN 300	CFO, CLO, PEN
SN 333	CFO, CLO, PEN, SUT
SN 334	CFO, CLO, CIP, GEN, CLI, ERI, PEN, SUT
SN 335	CFO, CLI, PEN
SN 338	CFO, CIP, GEN, ERI, CLI, PEN, SUT
SN 407	CFO, CLO, CIP, ERI, PEN, SUT
SN 427	CFO, CLO, CIP, ERI, PEN, SUT
SN 436	CFO, CLO, CIP, GEN, ERI, CLI, PEN, SUT
SN 442	CFO, CIP, GEN, ERI, CLI, PEN, SUT
SN 475	ERI, CLI, PEN, SUT
SN 484	GEN, PEN
SN 487	ERI, CLI, PEN, SUT
SN 500	PEN

CFO, cefoxitin; CLO, chlorafenicol; CIP, cyprofloxacin; GEN, gentamycin, CLI, clindamycin; ERI, erythromycin; PEN, penicillin; SUT, sulfamethoxazole–trimethoprim